Tenaya Therapeutics, Inc.

NASDAQ:TNYA

1.91 (USD) • At close October 22, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -124.084-123.665-72.721-38.395-26.231
Depreciation & Amortization 8.6876.4672.9612.4831.989
Deferred Income Tax 3.28200.1920.033-0.082
Stock Based Compensation 15.30911.4672.950.7410.414
Change In Working Capital -5.648-0.8494.742-0.234-0.25
Accounts Receivables 00000
Inventory 00000
Accounts Payables -3.2821.668.60.1420.397
Other Working Capital -2.366-2.509-3.858-0.376-0.647
Other Non Cash Items 0.3822.1561.064-0.0750.064
Operating Cash Flow -102.072-104.424-60.812-35.447-24.096
Investing Activities:
Investments In Property Plant And Equipment -1.239-20.63-25.121-9.763-2.926
Acquisitions Net 00000.003
Purchases Of Investments -56.644-140.476-213.4430-12.657
Sales Maturities Of Investments 106.623244.7502.75310
Other Investing Activites -0.0250.008-0.2130.003-0.003
Investing Cash Flow 48.71583.652-238.564-7.01-5.583
Financing Activities:
Debt Repayment 00000
Common Stock Issued 4.5577.387188.541147.26930.514
Common Stock Repurchased 00-0.013-0.001-0.003
Dividends Paid 00000
Other Financing Activities -0.5010.3820.4420.1470.031
Financing Cash Flow 4.04977.767208.97147.26830.511
Other Information:
Effect Of Forex Changes On Cash -0.2830000
Net Change In Cash -49.59156.995-90.406104.8110.832
Cash At End Of Period 45.68195.67138.676129.08224.271